![]()
展鹏
-
教授
博士生导师
硕士生导师
- 性别：男
- 毕业院校：山东大学
- 学历：博士研究生毕业
- 学位：医学博士学位
- 在职信息：在职
- 所在单位：药学院
- 入职时间： 2010-07-26
- 办公地点：山东大学国家大学生科技园（二环南路）3号楼14层1435房间
- 联系方式：13793130595
- 电子邮箱：zhanpeng1982@sdu.edu.cn
访问量：
-
[21]
刘新泳.
Overview of Recent Strategic Advances in Medicinal Chemistry.
J Med Chem,
2019.
-
[22]
刘新泳.
Development of a practical synthesis of etravirine via a microwave-promoted amination.
chemistry central Journal,
2018.
-
[23]
黄伯世.
Design, synthesis, and biological evaluation of piperidinyl-substituted [1,2,4]triazolo[1,5-a]pyrimi.
Chemical Biology & Drug Design,
97,
67,
2021.
-
[24]
张涛.
The development of an effective synthetic route of rilpivirine.
BMC CHEMISTRY,
15,
2021.
-
[25]
姜向毅.
Exploiting the tolerant region I of the non-nucleoside reverse transcriptase inhibitor (NNRTI) bindi.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
213,
2021.
-
[26]
孙彦莹.
Identification of novel potent HIV-1 inhibitors by exploiting the tolerant regions of the NNRTIs bin.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
214,
2021.
-
[27]
高萍.
Novel indolylarylsulfone derivatives as covalent HIV-1 reverse transcriptase inhibitors specifically.
BIOORGANIC & MEDICINAL CHEMISTRY Journal,
30,
2021.
-
[28]
封达.
Design, synthesis, and evaluation of "dual-site"-binding diarylpyrimidines targeting both NNIBP and .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
211,
2021.
-
[29]
武高禅.
Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
158,
478,
2018.
-
[30]
张硕.
Efficient drug discovery by rational lead hybridization based on crystallographic overlay.
Drug Discovery Today,
24,
805,
2019.
-
[31]
康东伟.
Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 N.
《Journal of Medicinal Chemistry》,
63,
1298,
2020.
-
[32]
康东伟.
Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorab.
《Journal of Medicinal Chemistry》,
63,
4837,
2020.
-
[33]
康东伟.
In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic ch.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
193,
2020.
-
[34]
康东伟.
Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted th.
ACTA PHARMACEUTICA SINICA B,
10,
878,
2020.
-
[35]
康东伟.
2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evalua.
《Journal of Medicinal Chemistry》,
64,
4239,
2021.
-
[36]
封达.
Design, synthesis, and evaluation of "dual-site"-binding diarylpyrimidines targeting both NNIBP and .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
211,
2021.
-
[37]
汪昭.
Targeting dual tolerant regions of binding pocket: Discovery of novel morpholine-substituted diarylp.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
206,
2020.
-
[38]
康东伟.
Structure-Activity Relationship Exploration of NNIBP Tolerant Region I Leads to Potent HIV-1 NNRTIs.
ACS INFECTIOUS DISEASES,
6,
2225,
2020.
-
[39]
康东伟.
Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRT.
ACS Medicinal Chemistry Letters,
9,
370,
2018.
-
[40]
Yang, Yang.
Structural basis for potent and broad inhibition of HIV-1 RT by thiophene[3,2-d] pyrimidine non-nucl.
Elife,
7,
2018.
